Edwards Lifesciences Current Ratio 2010-2024 | EW
Current and historical current ratio for Edwards Lifesciences (EW) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Edwards Lifesciences current ratio for the three months ending September 30, 2024 was 3.46.
| Edwards Lifesciences Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-09-30 | $6.73B | $1.94B | 3.46 |
| 2024-06-30 | $4.52B | $1.22B | 3.71 |
| 2024-03-31 | $4.17B | $1.11B | 3.76 |
| 2023-12-31 | $4.04B | $1.20B | 3.38 |
| 2023-09-30 | $4.07B | $1.24B | 3.28 |
| 2023-06-30 | $3.65B | $1.16B | 3.15 |
| 2023-03-31 | $3.26B | $1.08B | 3.01 |
| 2022-12-31 | $3.10B | $1.02B | 3.03 |
| 2022-09-30 | $3.51B | $0.92B | 3.83 |
| 2022-06-30 | $3.26B | $0.97B | 3.37 |
| 2022-03-31 | $3.24B | $0.95B | 3.41 |
| 2021-12-31 | $3.18B | $1.03B | 3.08 |
| 2021-09-30 | $3.52B | $0.97B | 3.64 |
| 2021-06-30 | $3.32B | $0.89B | 3.75 |
| 2021-03-31 | $3.07B | $0.80B | 3.84 |
| 2020-12-31 | $3.09B | $0.89B | 3.46 |
| 2020-09-30 | $2.98B | $0.85B | 3.52 |
| 2020-06-30 | $2.69B | $0.87B | 3.08 |
| 2020-03-31 | $2.51B | $0.75B | 3.36 |
| 2019-12-31 | $2.98B | $0.90B | 3.31 |
| 2019-09-30 | $2.74B | $0.78B | 3.53 |
| 2019-06-30 | $2.36B | $0.70B | 3.38 |
| 2019-03-31 | $2.37B | $0.65B | 3.66 |
| 2018-12-31 | $2.29B | $0.88B | 2.61 |
| 2018-09-30 | $2.91B | $1.26B | 2.31 |
| 2018-06-30 | $2.70B | $1.45B | 1.86 |
| 2018-03-31 | $2.72B | $1.32B | 2.07 |
| 2017-12-31 | $2.55B | $1.42B | 1.80 |
| 2017-09-30 | $2.57B | $0.74B | 3.49 |
| 2017-06-30 | $2.28B | $0.56B | 4.06 |
| 2017-03-31 | $2.02B | $0.59B | 3.45 |
| 2016-12-31 | $2.24B | $0.53B | 4.21 |
| 2016-09-30 | $2.17B | $0.53B | 4.08 |
| 2016-06-30 | $1.99B | $0.48B | 4.15 |
| 2016-03-31 | $1.82B | $0.46B | 3.97 |
| 2015-12-31 | $2.05B | $0.48B | 4.30 |
| 2015-09-30 | $2.15B | $0.53B | 4.03 |
| 2015-06-30 | $2.30B | $0.45B | 5.16 |
| 2015-03-31 | $2.26B | $0.41B | 5.56 |
| 2014-12-31 | $2.23B | $0.43B | 5.24 |
| 2014-09-30 | $2.31B | $0.43B | 5.40 |
| 2014-06-30 | $2.28B | $0.54B | 4.22 |
| 2014-03-31 | $1.60B | $0.36B | 4.50 |
| 2013-12-31 | $1.73B | $0.35B | 4.99 |
| 2013-09-30 | $1.57B | $0.34B | 4.69 |
| 2013-06-30 | $1.39B | $0.31B | 4.43 |
| 2013-03-31 | $1.36B | $0.30B | 4.53 |
| 2012-12-31 | $1.29B | $0.35B | 3.72 |
| 2012-09-30 | $1.39B | $0.30B | 4.65 |
| 2012-06-30 | $1.28B | $0.28B | 4.50 |
| 2012-03-31 | $1.19B | $0.27B | 4.48 |
| 2011-12-31 | $1.17B | $0.34B | 3.49 |
| 2011-09-30 | $1.18B | $0.30B | 3.91 |
| 2011-06-30 | $1.22B | $0.31B | 3.88 |
| 2011-03-31 | $1.15B | $0.45B | 2.58 |
| 2010-12-31 | $1.03B | $0.34B | 3.06 |
| 2010-09-30 | $0.99B | $0.38B | 2.60 |
| 2010-06-30 | $0.92B | $0.25B | 3.71 |
| 2010-03-31 | $0.87B | $0.24B | 3.60 |
| 2009-12-31 | $0.89B | $0.29B | 3.06 |
| 2009-09-30 | $0.88B | $0.30B | 2.96 |
| 2009-06-30 | $0.75B | $0.25B | 3.04 |
| 2009-03-31 | $0.65B | $0.20B | 3.24 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $42.188B | $6.005B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $202.480B | 24.70 |
| Intuitive Surgical (ISRG) | United States | $196.045B | 102.50 |
| Alcon (ALC) | Switzerland | $42.794B | 28.63 |
| IQVIA Holdings (IQV) | United States | $36.777B | 20.26 |
| IDEXX Laboratories (IDXX) | United States | $35.676B | 42.01 |
| DexCom (DXCM) | United States | $30.357B | 45.72 |
| Waters (WAT) | United States | $22.803B | 33.72 |
| STERIS (STE) | Ireland | $21.310B | 24.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.157B | 0.00 |
| Hologic (HOLX) | United States | $17.098B | 18.47 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.119B | 14.49 |
| Sysmex ADR (SSMXY) | Japan | $13.255B | 0.00 |
| Globus Medical (GMED) | United States | $11.345B | 28.73 |
| Penumbra (PEN) | United States | $9.105B | 89.18 |
| Masimo (MASI) | United States | $9.091B | 43.99 |
| Teleflex (TFX) | United States | $8.576B | 13.68 |
| Glaukos (GKOS) | United States | $7.735B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.949B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.675B | 26.50 |
| Veracyte (VCYT) | United States | $3.420B | 102.63 |
| Inari Medical (NARI) | United States | $2.990B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.699B | 15.58 |
| Nihon Kohden (NHNKY) | Japan | $2.361B | 17.93 |
| TransMedics (TMDX) | United States | $2.291B | 72.62 |
| Elekta AB (EKTAY) | Sweden | $2.165B | 19.47 |
| Tandem Diabetes Care (TNDM) | United States | $1.978B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.860B | 9.72 |
| RxSight (RXST) | United States | $1.739B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.365B | 0.00 |
| Artivion (AORT) | United States | $1.243B | 82.39 |
| Pulse Biosciences (PLSE) | United States | $1.215B | 0.00 |
| OPKO Health (OPK) | United States | $1.085B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.849B | 14.43 |
| Paragon 28 (FNA) | United States | $0.840B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.712B | 0.00 |
| IRadimed (IRMD) | United States | $0.687B | 37.11 |
| Mesa Laboratories (MLAB) | United States | $0.674B | 15.88 |
| AxoGen (AXGN) | United States | $0.656B | 0.00 |
| SiBone (SIBN) | United States | $0.567B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.561B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.556B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.512B | 30.12 |
| Treace Medical Concepts (TMCI) | United States | $0.494B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.439B | 23.75 |
| Delcath Systems (DCTH) | United States | $0.380B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.372B | 0.00 |
| NeuroPace (NPCE) | United States | $0.337B | 0.00 |
| CVRx (CVRX) | United States | $0.327B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.284B | 0.00 |
| Inogen (INGN) | United States | $0.226B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| Accuray (ARAY) | United States | $0.202B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.196B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.174B | 0.00 |
| Nevro (NVRO) | United States | $0.157B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.145B | 15.49 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.095B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.092B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| 908 Devices (MASS) | United States | $0.080B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.054B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.045B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.040B | 0.00 |
| Spectral AI (MDAI) | United States | $0.039B | 0.00 |
| Neuronetics (STIM) | United States | $0.039B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |